Circulating galectin-3 in infections and non-infectious inflammatory diseases

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 12, 2013, Pages 1605-1610

  Ten Oever, J ^a   Giamarellos Bourboulis, E J ^b   Van De Veerdonk, F L ^a   Stelma, F F ^a   Simon, A ^a   Janssen, M ^c   Johnson, M ^d   Pachot, A ^e   Kullberg, B J ^a   Joosten, L A B ^a   Netea, M G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GALECTIN 3;

ADULT; AREA UNDER THE CURVE; ARTICLE; AUTOINFLAMMATORY DISEASE; BACTERIAL INFECTION; CANDIDEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FALSE POSITIVE RESULT; FEMALE; GOUT; HUMAN; INFLAMMATORY DISEASE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MYCOSIS; PANCREATITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS;

AUTOIMMUNE DISEASES; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMMUNICABLE DISEASES; FEMALE; GALECTIN 3; GOUT; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PANCREATITIS;

EID: 84888008611     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1919-4     Document Type: Article

References (19)

1. Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 230(1):160-171. doi: 10.1111/j.1600-065X.2009.00794.x
2. Sato S, St-Pierre C, Bhaumik P, Nieminen J (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230(1):172-187. doi: 10.1111/j.1600-065X.2009.00790.x
3. Nieminen J, Kuno A, Hirabayashi J, Sato S (2007) Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem 282(2):1374-1383. doi: 10.1074/jbc.M604506200
4. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306(5693):120-124. doi: 10.1126/science.1102109
5. Fradin C, Poulain D, Jouault T (2000) beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect Immun 68(8):4391-4398
6. Linden JR, De Paepe ME, Laforce-Nesbitt SS, Bliss JM (2013) Galectin-3 plays an important role in protection against disseminated candidiasis. Med Mycol. doi: 10.3109/13693786.2013.770607
7. Jouault T, El Abed-El Behi M, Martínez-Esparza M, Breuilh L, Trinel PA, Chamaillard M, Trottein F, Poulain D (2006) Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177(7):4679-4687
8. Esteban A, Popp MW, Vyas VK, Strijbis K, Ploegh HL, Fink GR (2011) Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages. Proc Natl Acad Sci U S A 108(34):14270-14275. doi: 10.1073/pnas.1111415108
9. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG (2006) Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 177(7):4718-4726
10. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839-843
11. Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG (2012) Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 54(4):502-510. doi: 10.1093/cid/cir827
12. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272(1):55-64. doi: 10.1111/j.1365-2796.2011.02476.x
13. Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK (2011) Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clin Cancer Res 17(2):267-274. doi: 10.1158/1078-0432.CCR-10-1937
14. Lok DJ, Van Der Meer P, de la Porte PW, Lipsic E, Van Wijngaarden J, Hillege HL, van Veldhuisen DJ (2010) Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99(5):323-328. doi: 10.1007/s00392-010-0125-y
15. Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S (2000) Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 6(4):1389-1393
16. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148(12):2642-2645
17. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49(9):3640-3645. doi: 10.1128/AAC.49.9.3640-3645.2005
18. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA; Cava Study Group (2009) Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37(5):1624-1633. doi: 10.1097/CCM. 0b013e31819daa14
19. Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9-18. doi: 10.1111/1469-0691.12038